Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Names Michael R. Stewart to Board of Directors

IRVINGTON, N.Y., Aug. 5, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
August 04, 2014 16:01 ET | Source: MELA Sciences

MELA Sciences to Report Second Quarter 2014 Financial Results on Wednesday, August 13

IRVINGTON, N.Y., Aug. 4, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 29, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Regains Compliance With NASDAQ Listing Requirements

IRVINGTON, N.Y., July 29, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 25, 2014 19:03 ET | Source: MELA Sciences

MELA Sciences Reports the Closing of Its Private Placement

IRVINGTON, N.Y., July 25, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...
July 24, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Announces New Study Results Demonstrating Improved Diagnostic Accuracy for Resident Dermatologists When Utilizing MelaFind Predictive Probability Information

IRVINGTON, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 22, 2014 09:00 ET | Source: MELA Sciences

MELA Sciences Announces $27.3 Million At The Market Private Placement of Preferred Stock, Debentures and Warrants

IRVINGTON, N.Y., July 22, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 10, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code for the MelaFind System

IRVINGTON, N.Y., July 10, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), announced today that it has taken the first step in the process of seeking insurance reimbursement for its...
July 03, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Announces Pending One-for-Ten Reverse Stock Split

IRVINGTON, N.Y., July 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
June 03, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Initiates First Study to Investigate Real-World Clinical Impact of the MelaFind System on Melanoma Biopsy Decision

IRVINGTON, N.Y., June 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...